Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1977 1
1979 1
1982 1
2009 1
2010 1
2018 1
2019 1
2020 1
2022 1
2023 1
2024 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

13 results

Results by year

Filters applied: . Clear all
Page 1
Intravenous tenecteplase compared with alteplase for acute ischaemic stroke in Canada (AcT): a pragmatic, multicentre, open-label, registry-linked, randomised, controlled, non-inferiority trial.
Menon BK, Buck BH, Singh N, Deschaintre Y, Almekhlafi MA, Coutts SB, Thirunavukkarasu S, Khosravani H, Appireddy R, Moreau F, Gubitz G, Tkach A, Catanese L, Dowlatshahi D, Medvedev G, Mandzia J, Pikula A, Shankar J, Williams H, Field TS, Manosalva A, Siddiqui M, Zafar A, Imoukhuede O, Hunter G, Demchuk AM, Mishra S, Gioia LC, Jalini S, Cayer C, Phillips S, Elamin E, Shoamanesh A, Subramaniam S, Kate M, Jacquin G, Camden MC, Benali F, Alhabli I, Bala F, Horn M, Stotts G, Hill MD, Gladstone DJ, Poppe A, Sehgal A, Zhang Q, Lethebe BC, Doram C, Ademola A, Shamy M, Kenney C, Sajobi TT, Swartz RH; AcT Trial Investigators. Menon BK, et al. Lancet. 2022 Jul 16;400(10347):161-169. doi: 10.1016/S0140-6736(22)01054-6. Epub 2022 Jun 29. Lancet. 2022. PMID: 35779553 Clinical Trial.
Tenecteplase versus standard of care for minor ischaemic stroke with proven occlusion (TEMPO-2): a randomised, open label, phase 3 superiority trial.
Coutts SB, Ankolekar S, Appireddy R, Arenillas JF, Assis Z, Bailey P, Barber PA, Bazan R, Buck BH, Butcher KS, Camden MC, Campbell BCV, Casaubon LK, Catanese L, Chatterjee K, Choi PMC, Clarke B, Dowlatshahi D, Ferrari J, Field TS, Ganesh A, Ghia D, Goyal M, Greisenegger S, Halse O, Horn M, Hunter G, Imoukhuede O, Kelly PJ, Kennedy J, Kenney C, Kleinig TJ, Krishnan K, Lima F, Mandzia JL, Marko M, Martins SO, Medvedev G, Menon BK, Mishra SM, Molina C, Moussaddy A, Muir KW, Parsons MW, Penn AMW, Pille A, Pontes-Neto OM, Roffe C, Serena J, Simister R, Singh N, Spratt N, Strbian D, Tham CH, Wiggam MI, Williams DJ, Willmot MR, Wu T, Yu AYX, Zachariah G, Zafar A, Zerna C, Hill MD; TEMPO-2 investigators. Coutts SB, et al. Lancet. 2024 Jun 15;403(10444):2597-2605. doi: 10.1016/S0140-6736(24)00921-8. Epub 2024 May 17. Lancet. 2024. PMID: 38768626 Clinical Trial.
Thrombolysis With Tenecteplase for Minor Disabling Stroke: Secondary Analysis of the TEMPO-2 Randomized Clinical Trial.
Zhang Y, Buck BH, Barber PA, Chatterjee K, Clarke B, Choi PMC, Hunter G, Ganesh A, Mishra SM, Williams D, Campbell BCV, Dowlatshahi D, Butcher KS, Krishnan K, Wiggam MI, Kleinig TJ, Muir KW, Zerna C, Field TS, Goyal M, Yu AYX, Roffe C, Demchuck AM, Parsons MW, Bazan R, Ankolekar S, Kennedy J, Menon BK, Mandzia JL, Pille A, Kelly PJ, Marko M, Singh N, Vatanpour S, Lima FO, Catanese L, Horn M, Ghia D, Ferrari J, Greisenegger S, Hill MD, Coutts SB; TEMPO-2 Investigators. Zhang Y, et al. JAMA Neurol. 2025 Oct 27:e254152. doi: 10.1001/jamaneurol.2025.4152. Online ahead of print. JAMA Neurol. 2025. PMID: 41143808
Effects of a Province-wide Triaging System for TIA: The ASPIRE Intervention.
Jeerakathil TJ, Yu AYX, Choi PMC, Fang S, Shuaib A, Majumdar SR, Demchuk AM, Butcher K, Watson TJ, Dean N, Gordon D, Hill MD, Edmond C, Coutts SB; ASPIRE Investigators. Jeerakathil TJ, et al. Neurology. 2023 May 16;100(20):e2093-e2102. doi: 10.1212/WNL.0000000000207201. Epub 2023 Mar 28. Neurology. 2023. PMID: 36977597 Free PMC article.
Provincial Door-to-Needle Improvement Initiative Results in Improved Patient Outcomes Across an Entire Population.
Kamal N, Jeerakathil T, Stang J, Liu M, Rogers E, Smith EE, Demchuk AM, Siddiqui M, Mann B, Bestard J, Lang E, Shand E, Benard M, Collins L, Martin K, Hartley C, Reiber M, Valaire S, Mrklas KJ, Hill MD; QuICR Alberta Stroke Program. Kamal N, et al. Among authors: shand e. Stroke. 2020 Aug;51(8):2339-2346. doi: 10.1161/STROKEAHA.120.029734. Epub 2020 Jul 9. Stroke. 2020. PMID: 32640947 Free article.
Amyloid in basal cell carcinomas.
Weedon D, Shand E. Weedon D, et al. Among authors: shand e. Br J Dermatol. 1979 Aug;101(2):141-6. doi: 10.1111/j.1365-2133.1979.tb05598.x. Br J Dermatol. 1979. PMID: 385032
Safety and Real-World Effectiveness in the Transition from Alteplase to Tenecteplase for Stroke Treatment.
Halabi ML, Stang J, Menon BK, Buck BH, Job-McIntosh C, Wilton SB, Valaire S, Mann B, Collins L, Taralson C, Beaulieu L, Shand E, Hartley C, Dalgleish C, Nickonchuk A, Erfle S, Imoukhuede O, Manosalva A, Lin K, Coutts SB, Jeerakathil T, Shuaib A, Demchuk AM, Hill MD. Halabi ML, et al. Among authors: shand e. Can J Neurol Sci. 2025 Jun 27:1-6. doi: 10.1017/cjn.2025.10121. Online ahead of print. Can J Neurol Sci. 2025. PMID: 40571961
13 results